Patrick Cox's Tech Digest - View by Tag "fda policies"

One of the most encouraging trends in health care is the emergence of the “Right to Try” movement. This is an effort to change FDA policies that keep dying patients from getting access to investigational drugs. These are drugs that have gone through initial safety studies but not the entire series of clinical trials.

Connect with Mauldin

Before you go...

Subscribe to Patrick Cox's Tech Digest

Don't leave your free subscription to Tech Digest on the table! Sign up for the biotech, science, and technology stories that can impact your portfolio.

Technology is king—and not just with health and biotech scientists. Investors who are current on the latest trends and developments stay one step ahead of the markets. In Tech Digest, Patrick Cox delivers the news, data, and analysis you need to know to keep your portfolio (and maybe even yourself) healthy.

Sign up today, and you'll get all the breaking news coming out of the tech industry, with expert analysis only Patrick Cox can provide.

Read why pharma and biotech stocks could be in trouble under Trump

Learn how the new FDA chief could dramatically alter the new drug approval process

Discover what the Department of Defense has to do with organ donation (and why it matters)